Let's reverse that back to you. What is it that
Post# of 9144
Posted On: 09/02/2014 10:21:06 PM
Re: rayludwiczak #204
Let's reverse that back to you.
What is it that you are waiting for? I know I don't expect financials until they can paint a very positive picture. Things can even be decent financially but until they are very good it doesn't make any sense for them to be posted until they are really, really good because of the continual sniping and bashing that has gone on for the past three years. For me it is concentrated on the N-Assay with some positive revenues flowing from the sale of petri dish and agar in the advanced packaging. I expect those revenues to start building more with the sales addition hired in May but the real "mother lode" is the N-Assay and that (I think) is being positioned to go and the design and manufacturing being developed.
The potential of the N-Assay is so significant and the volumes implicit in the outside manufacturing so large that it is as if there will be a new company compared to current operations--an entirely different scale. Other than that I don't know what to say. I can actually see one of the big companies possibly making a bid for the N-Assay. They won't do it for the petri stuff because they are "milking the cow" and all the incentives are business as usual. Not the same with the N-Assay. But that technology--scaled to volume externally--can expand rapidly even if no one tries to buy it up. So we will see. Now it is your turn. Tell us your thoughts.
What is it that you are waiting for? I know I don't expect financials until they can paint a very positive picture. Things can even be decent financially but until they are very good it doesn't make any sense for them to be posted until they are really, really good because of the continual sniping and bashing that has gone on for the past three years. For me it is concentrated on the N-Assay with some positive revenues flowing from the sale of petri dish and agar in the advanced packaging. I expect those revenues to start building more with the sales addition hired in May but the real "mother lode" is the N-Assay and that (I think) is being positioned to go and the design and manufacturing being developed.
The potential of the N-Assay is so significant and the volumes implicit in the outside manufacturing so large that it is as if there will be a new company compared to current operations--an entirely different scale. Other than that I don't know what to say. I can actually see one of the big companies possibly making a bid for the N-Assay. They won't do it for the petri stuff because they are "milking the cow" and all the incentives are business as usual. Not the same with the N-Assay. But that technology--scaled to volume externally--can expand rapidly even if no one tries to buy it up. So we will see. Now it is your turn. Tell us your thoughts.
(0)
(0)